Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wardelmann

Showing results (71-80 of 248) with videos related to

Pageof 25
Sort By:
Journal of Cancer Research and Clinical Oncology|November 13, 2008
Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signalingSebastian Zimmer, Philip Kahl, Theresa M Buhl, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 30, 2015
Erratum to: The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cellsKonrad Steinestel, Stefan Eder, Konstantin Ehinger, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 2, 2015
The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cellsKonrad Steinestel, Stefan Eder, Konstantin Ehinger, et al.
Oncology Research and Treatment|June 28, 2023
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other CountriesSylke Ruth Zeissig, Katharina Emrich, Fabian Reinwald, et al.
BMC Public Health|February 14, 2018
Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in GermanyMeike Ressing, Eva Wardelmann, Peter Hohenberger, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2016
Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSGViktor Grünwald, Saskia Litière, Robin Young, et al.
Anti-Cancer Drugs|June 9, 2015
Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell linesRebekka Unland, Dagmar Clemens, Ulrike Heinicke, et al.
Lancet (London, England)|August 19, 2007
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational studyChristiane K Kuhl, Simone Schrading, Heribert B Bieling, et al.
Oncotarget|December 22, 2016
Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNSTBirthe Heitkötter, Marcel Trautmann, Inga Grünewald, et al.
Cancer Letters|October 30, 2016
Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K)Stefan Eder, Annette Arndt, Andreas Lamkowski, et al.
Pageof 25

Showing results (71-80 of 248) with videos related to

Sort By:
Pageof 25
Journal of Cancer Research and Clinical Oncology|November 13, 2008
Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signalingSebastian Zimmer, Philip Kahl, Theresa M Buhl, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 30, 2015
Erratum to: The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cellsKonrad Steinestel, Stefan Eder, Konstantin Ehinger, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 2, 2015
The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cellsKonrad Steinestel, Stefan Eder, Konstantin Ehinger, et al.
Oncology Research and Treatment|June 28, 2023
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other CountriesSylke Ruth Zeissig, Katharina Emrich, Fabian Reinwald, et al.
BMC Public Health|February 14, 2018
Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in GermanyMeike Ressing, Eva Wardelmann, Peter Hohenberger, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2016
Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSGViktor Grünwald, Saskia Litière, Robin Young, et al.
Anti-Cancer Drugs|June 9, 2015
Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell linesRebekka Unland, Dagmar Clemens, Ulrike Heinicke, et al.
Lancet (London, England)|August 19, 2007
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational studyChristiane K Kuhl, Simone Schrading, Heribert B Bieling, et al.
Oncotarget|December 22, 2016
Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNSTBirthe Heitkötter, Marcel Trautmann, Inga Grünewald, et al.
Cancer Letters|October 30, 2016
Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K)Stefan Eder, Annette Arndt, Andreas Lamkowski, et al.
Pageof 25